Article info
PDFOriginal article
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer
- Correspondence to:
Dr Glen Kristiansen
Institute of Pathology, Charité Hospital, Campus Mitte, Schumannstr 20/21, D-10117 Berlin, Germany; glen.kristiansen{at}charite.de
Citation
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer
Publication history
- Accepted September 20, 2005
- First published February 16, 2006.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Clinical Pathology